Oak Hill, WV (CNN) – Doctors warn asthma patients about a significant change regarding inhalers.
Starting January 1, the asthma inhaler Flovent, made by GSK, will no longer be available on pharmacy shelves.
Physicians say an authorized generic version to take its place will work just as well, but it doesn’t appear to be covered as widely by insurers.
Doctors are urging patients to act now to get new prescriptions if necessary and address coverage issues, especially since it’s respiratory virus season.
Industry insiders say GSK is discontinuing Flovent because of Medicaid rebate changes forcing the company to pay hefty penalties for hiking prices.
Sponsored Content
